Composition
- Active ingredients
- NATALIZUMAB-SZTN 300MG/15ML(20MG/ML)
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761322.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Tyruko
- Active substance
- natalizumab-sztn
- Drug class
- Monoclonal antibodies
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Sandoz Inc
- Status
- Prescription
- FDA approval
- 24 Aug 2023
- Application
- BLA761322-001
- RxCUI
- 2725175